Meet our CEO, Johannes Schmidt, and CTO, Thomas Frischmuth, at Bio€quity 2024, the event where CEOs and investors gather to network, partner, and debate critical issues facing the biotech industry. Johannes Schmidt will present our novel targeted RNA-therapy approach on the brink of clinical testing in the showcase session on Tuesday, 14th May.
12th – 14th May 2024
Kursaal Elkargunea Center
Zurriola Hiribidea, 1
20002 Donostia – San Sebastián